A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus
about
Hepatitis B: future curative strategiesA 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors.Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections.Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Present and future therapies of hepatitis B: From discovery to cureFunctional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsespEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences.Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?HBV and the immune response.Immune Response in Hepatitis B Virus Infection.Advances in therapeutics for chronic hepatitis B.New paradigms in hepatitis B management: only diamonds are forever.Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.Microfluidic models for adoptive cell-mediated cancer immunotherapiesPromising new strategies for hepatocellular carcinoma.HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity.Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers.Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg SeroconversionT cell receptor-therapy in HBV-related hepatocellularcarcinomaMolecular profile of the T cell receptor beta variable in peripheral blood lymphocytes from chronic asymptomatic HBV carriers.Immunobiology of hepatitis B virus infection.Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future.Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation.Immunotherapy for Chronic Hepatitis B Virus Infection.Development of anti-human mesothelin-targeted chimeric antigen receptor (CAR) messenger RNA (mRNA)-transfected peripheral blood lymphocytes (CARMA-hMeso) for ovarian cancer therapy.Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.Immunotherapy of hepatocellular carcinoma
P2860
Q27011623-F069F7F5-1D46-4C18-AF64-CAF624690205Q33803754-C4DDABD7-26E4-4D76-96E8-4BCBE78CA441Q35075107-E5A4A95C-BC7B-4840-9732-4F5CD0069793Q35102451-B287F743-E566-4B6B-8C7B-C8ECAD7C8823Q35308252-B65154DF-3E00-465B-9983-298E95C97779Q36378278-B66E7954-246C-4FEA-AAB9-139E8FEF5016Q36865009-EDC8BA58-29B2-4A69-AAB2-0E5D7C8D04EEQ37238914-5561DA95-D797-4684-96DF-289971F9089EQ38289729-D7071E4D-D7C5-4190-978E-2BEA6E86482DQ38295864-99A9443A-E8B7-4213-AC41-8E2BA6994C17Q38541811-5035D8DB-498B-41BC-91BC-A8922C903394Q38585657-31654093-6DF5-41A4-9CD0-10A48A1307DDQ38588187-FC170A2B-E148-423E-A82E-2FE75A98D37DQ38665181-170E9254-57BF-45B8-B0E8-EC7256F7D68FQ38715318-77719EBA-7ADE-426A-A2CF-1F5C1F3D6762Q38835747-AA49549C-D22C-443B-8635-F4C5E4A42534Q38936589-C2FD0D51-96CE-4E49-8500-8B7D766139D2Q39244731-C4AEDCB5-E7D4-4637-A571-A24C9C2741B2Q39253341-AD6AA245-5E5B-4E78-B557-9922D0A56EEFQ40064246-8F3F442B-28A3-4BC3-B8B4-A6133808A50EQ40089302-148FE290-9285-40FE-B03A-ADFB7D2437F7Q40486931-9DECB510-57C8-498D-873C-3257EB9A6508Q41117987-C67F3863-B615-4AFD-9FF6-038D19B1A676Q41461264-217492E4-8F14-4469-BAC5-8D40CEADB0CEQ41694097-B04675A4-E7D6-4680-AED0-86065B926B1FQ42093888-10968E09-0242-4C6B-AC57-3803B80D6BE1Q42221744-03589F26-5613-4FDA-AB14-BB99BB6E3298Q47556416-6D210609-6F91-4CD5-9745-6F7488A2C782Q50025535-E731F135-4B71-4792-9C66-C58B68F4EFEEQ54252192-EA522FB1-AD1B-46B4-89F6-4390E24F0490Q55715332-3CEA4ECA-ED44-4FD8-ABB3-D39941AD2652Q56896669-B25BD326-A81F-4FCB-9393-CC3B4AC1719C
P2860
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A practical approach to immuno ...... cted against hepatitis B virus
@en
A practical approach to immuno ...... ted against hepatitis B virus.
@nl
type
label
A practical approach to immuno ...... cted against hepatitis B virus
@en
A practical approach to immuno ...... ted against hepatitis B virus.
@nl
prefLabel
A practical approach to immuno ...... cted against hepatitis B virus
@en
A practical approach to immuno ...... ted against hepatitis B virus.
@nl
P2093
P2860
P356
P1476
A practical approach to immuno ...... cted against hepatitis B virus
@en
P2093
Adam J Gehring
Adeline Chia
Alice Soh Meoy Ong
Dario Campana
Hans Stauss
Laurent Renia
Matti Sällberg
Nasirah Banu
Noriko Shimasaki
Rossarin Suwanarusk
P2860
P356
10.1038/MTNA.2013.43
P577
2013-08-13T00:00:00Z